Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo

Cytotechnology

Volumn 65, Issue 4, 2013, Pages 643-653

  Qin, Hai Xia ^a   Yang, Jun ^a   Cui, Hong Kai ^a   Li, Shao Ping ^a   Zhang, Wei ^a   Ding, Xiao Li ^a   Xia, Yong Hua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Aspirin; Cervical carcinoma; Reversine

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; CASPASE 3; CYCLIN D1; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; REVERSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER SIZE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

MURINAE; MUS;

EID: 84881164722     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-012-9520-8     Document Type: Article

References (32)

1. Anastasia L, Sampaolesi M, Papini N, Oleari D, Lamorte G, Tringali C, Monti E, Galli D, Tettamanti G, Cossu G, Venerando B (2006) Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. Cell Death Differ 13:2042-2051
2. Anastasia L, Pelissero G, Venerando B, Tettamanti G (2010) Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine. Cell Death Differ 17:1230-1237
3. Bunimov N, Laneuville O (2008) Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis. Cardiovasc Hematol Disord Drug Targets 8:268-277
4. Chen S, Zhang Q, Wu X, Schultz PG, Ding S (2004) Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126:410-411
5. De Luna-Bertos E, Ramos-Torrecillas J, García-Martínez O, Díaz-Rodríguez L, Ruiz C (2012) Effect of aspirin on cell growth of human MG-63 osteosarcoma line. ScientificWorldJournal 2012:834246
6. Ghosh N, Chaki R, Mandal V, Mandal SC (2010) COX-2 as a target for cancer chemotherapy. Pharmacol Rep 62:233-244
7. Harper DM (2009) Current prophylactic HPV vaccines and gynecologic premalignancies. Curr Opin Obstet Gynecol 21:457-464
8. Hsieh TC, Traganos F, Darzynkiewicz Z, Wu JM (2007) The 2, 6-disubstituted purine reversine induces growth arrest and polyploidy in human cancer cells. Int J Oncol 31:1293-1300
9. Hsieh CC, Hernández-Ledesma B, de Lumen BO (2011) Lunasin-aspirin combination against NIH/3T3 cells transformation induced by chemical carcinogens. Plant Foods Hum Nut 66:107-113
10. Hua SC, Chang TC, Chen HR, Lu CH, Liu YW, Chen SH, Yu HI, Chang YP, Lee YR (2012) Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells. Pharm Res 29:1990-2005
11. Im SR, Jang YJ (2012) Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells. Biochem Biophys Res Commun 424:65-70
12. Jemaà M, Galluzzi L, Kepp O, Boilève A, Lissa D, Senovilla L, Harper F, Pierron G, Berardinelli F, Antoccia A, Castedo M, Vitale I, Kroemer G (2012) Preferential killing of p53-deficient cancer cells by reversine. Cell Cycle 11:2149-2158
13. Jung DW, Williams DR (2011) Novel chemically defined approach to produce multipotent cells from terminally differentiated tissue syncytia. ACS Chem Biol 6:553-562
14. Khan Z, Khan N, Tiwari RP, Sah NK, Prasad GB, Bisen PS (2011) Biology of Cox-2: an application in cancer therapeutics. Curr Drug Targets 12:1082-1093
15. Kim YK, Choi HY, Kim NH, Lee W, Seo DW, Kang DW, Lee HY, Han JW, Park SW, Kim SN (2007) Reversine stimulates adipocyte differentiation and downregulates Akt and p70(s6k) signaling pathways in 3T3-L1 cells. Biochem Biophys Res Commun 358:553-558
16. Kumar A, Singh SM (2012) Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules. Mol Cell Biochem 371:43-54
17. Kuo CH, Lu YC, Tseng YS, Shi CS, Chen SH, Chen PT, Wu FL, Chang YP, Lee YR (2012) Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells. Breast Cancer. doi: 10.1007/s12282-012-0400-z
18. Lee YR, Wu WC, Ji WT, Chen JY, Cheng YP, Chiang MK, Chen HR (2012) Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy. J Biomed Sci 19:9
19. Lewis HD Jr, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE 3rd, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 309:396-403
20. Ma J, Waxman DJ (2008) Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther 7:3670-3684
21. Macdonald S (2002) Aspirin use to be banned in under 16 year olds. BMJ 325:988
22. Manrique C, Lastra G, Palmer J, Gardner M, Sowers JR (2008) Aspirin and Diabetes Mellitus: revisiting an old player. Ther Adv Cardiovasc Dis 2:37-42
23. McMillin DW, Delmore J, Weisberg E, Negri JM, Geer DC, Klippel S, Mitsiades N, Schlossman RL, Munshi NC, Kung AL, Griffin JD, Richardson PG, Anderson KC, Mitsiades CS (2010) Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med 16:483-489
24. Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480:480-489
25. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
26. Saraiya M, Nasser R, Zeng Y, Addya S, Ponnappan RK, Fortina P, Anderson DG, Albert TJ, Shapiro IM, Risbud MV (2010) Reversine enhances generation of progenitor-like cells by dedifferentiation of annulus fibrosus cells. Tissue Eng Part A 16:1443-1455
27. Shan SW, Tang MK, Chow PH, Maroto M, Cai DQ, Lee KK (2007) Induction of growth arrest and polycomb gene expression by reversine allows C2C12 cells to be reprogrammed to various differentiated cell types. Proteomics 7:4303-4316
28. Sohma I, Fujiwara Y, Sugita Y, Yoshioka A, Shirakawa M, Moon JH, Takiguchi S, Miyata H, Yamasaki M, Mori M, Doki Y (2011) Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer. Cancer Genomics Proteomics 8:39-47
29. Topalian SL, Weiner GJ, Pardoll DM (2011) Cancer immunotherapy comes of age. J Clin Oncol 29:4828-4836
30. Tu Z, Li H, Ma Y, Tang B, Tian J, Akers W, Achilefu S, Gu Y (2012) The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression. Mol Cell Biochem 366:111-122
31. Voutsadakis IA, Patrikidou A, Tsapakidis K, Karagiannaki A, Hatzidaki E, Stathakis NE, Papandreou CN (2010) Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib. Int J Colorectal Dis 25:795-804
32. Wang YH, Wu MW, Yang AK, Zhang WD, Sun J, Liu TR, Chen YF (2011) COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway. Med Oncol 28:S360-S366